BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/8/2021 4:20:46 PM | Browse: 110 | Download: 209
Publication Name World Journal of Clinical Oncology
Manuscript ID 60254
Country Pakistan
Category Immunology
Manuscript Type Minireviews
Article Title Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
Manuscript Source Unsolicited Manuscript
All Author List Kashif Asghar, Asim Farooq, Bilal Zulfiqar and Asif Loya
Funding Agency and Grant Number
Corresponding Author Kashif Asghar, DVM, PhD, Research Scientist, Department of Basic Science Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre 7A, Block R3, Johar Town, Lahore 54000, Pakistan. drkashifasghar@gmail.com
Key Words Indoleamine 2, 3-dioxygenase; Breast cancer; Therapeutic target; Prognostic marker; Immune responses; Immune escape
Core Tip Indoleamine 2,3-dioxygenase might be utilized as a potential biomarker and immunotherapeutic target in breast cancer patients.
Citation Asghar K, Farooq A, Zulfiqar B, Loya A. Review of 10 years of research on breast cancer patients: Focus on indoleamine 2, 3-dioxygenase. World J Clin Oncol 2020; 12(6): 429-436
Received
2020-10-22 13:10
Peer-Review Started
2020-10-22 13:11
To Make the First Decision
Return for Revision
2020-12-03 18:13
Revised
2020-12-30 13:21
Second Decision
2021-04-08 12:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-08 16:20
Articles in Press
2021-04-08 16:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-05-07 15:12
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com